Objectives. The purpose of this sfody WPI to elucidate whether the effectiveness of long&rm beta-blocker tkeropy could be predicted before this therapy is started, &&round, Long-term bfia.blwkw therapy has recently two reported to provide a favorabte elftct in treatment of congestive heart failure doe to dilated cardiomyopathy.
unsl;ar which subgroup of patients with dilated cardiomyopathy would be likely to benefit from long-term hetaThe purpose of this study was to elucidate whether the ebctiveness of long-term beta-blockade could be predicted from a variety of data, including histologic find&. before this therapy was begun in patients with dilated cardiomyopDilated cardiomyopathy is a heart muscle disease characterized by left ventricular dilation and impaired contraction of unknown cause, resulting in a poor prognosis. Several blocker therapy. investigators (I-l I) recently reported that long-term betablocker therapy could provide a favorable effect in treatment of congestive heart failure due to dilated cardiomyopathy. In these studies, it was shown that long-term beta-blocker therapy improved New York Heart Association functional athy. class, exercise capacity (l,2), hemodynamic state (3-6) and survival rate (7-9), and that withdrawat of betambfocking agents produced a deleterious effect (l&11). These results
Methods
revealed the usefulness of long-term beta-blocker therapy in rtients with dilated cardiomyopathy. However, there was a subgroup of patients with dilated cardiomyopathy who did not respond to the beta-blocker therapy (9,ll Evaluation of the effectiveness of long.term beta.blorker therapy. The effectiveness of long-term beta-blocker therapy was assessed again by echocardiography 12 months after the administration of metoprolol, because improvement was shown to be a slow process that takes from 3 to I2 months in our and other previous studies (4.5.1 I). According to the degree of improvement in functional class and left ventricular ejection fraction, patients were classified into two groups: good responders with improvement of at least one functional class or increase in ejeciion fraction of 80.10 and mr responders without such improvement with long-term betablocker therapy.
Statistical analysis. Results were expressed as mean value + SD. A two-factor repeated measures analysis of variance was used for paired data (comparison of echocardiographic data between before and 12 months after betablocker therapy) and unpaired data (comparisons between good and poor responders). The relation between the response to long-term bela-blocker therapy and the dominant rype of fibrosis was examined with a cbi-square test. A p value < 0.05 was considered significant.
Results
Response to lon@erm beta-blocker therapy. No patients showed deterioration of congestive heart failure as a result of metoprolol administration.
Fourteen patients had both symptomatic and objective improvement. In contrast, the other I2 patients had neither symptomatic nor objective improvement. The remaining four patients had improvement of one functional class without an increase in ejection fraction 20. IO. Accordingly, 18 oi 30 patients with dilated cardiomyopathy had a good response to long-term betablocker therapy, whereas the remaining I2 patients had a poor response. Ail but three patients received the final therapeutic dose of M) mg/day of metoprolol. These three patients (one good responder and two poor responders) received a dose of 40 mdday. There was no significant diierence in the final dose of metoprolol between good and poor responders. Comparison of baseline data in good and poor responders (Table I ). There were no significant differences between good and poor responders at entry in terms ofthe following: age, gender, functional class, hemodynamic variables such as heart rate, systemic blood pressure, pulmonary capillary wedge pressure, cardiac index and left ventricular enddiastolic, end-systolic dimensions and ejection fraction (Fig.   21 . The present study demonstrated that long-term betablocker therapy would be expected to be more effective in patients wirh less myocardial fibrosis, with the dominant type of fibrosis being interfa>cic&u rn:her than intercellular fibrosis. These results indicate that the extent and type of fibrosis in endomyocardial biopsy specimens might be imuortant factors for predicting the effectiveness of lorp-trm was a 50%'chnnce of deter&&n in the presence of the most seyere histologic change. whereas most patients with mild or moderate abnonualities should tolerate beta-blocker therapy. Thus. only tolerance IO bera-blocker thempy was discussed in their study (IS) . In the present study. we demonstnted lhrt histologic findings such as the dominant type and extent of fibrosis might be important factors for predicting the effectiveness of long-term beta-blocker therapy in paiients who are able to tolerate the drug.
Although good responders in this study actually had significantly less myocardial fibrosis than that of poor respenders. some patients wilh a similar extent of fibrosis showed various responses IO long-term beta-blockade. It is suggested that the extent of fibrosis might not be the only variable that explains the difference in the response to lone-term beta-blocker theraav. Converselv. it miaht be beta-blocker therapy. 2 1 18.2 to 39.3 1 34.4 months) . Therefore. it is suggested that the earlier therapy is begun, the n~ore e&c-tive it would be in patients with dilated cardiomyopalhy.
We also performed symptom-limited multistage supine bicycle ergometry. monitoring the hemodynamic variables with a SwanGanz catheter in 12 study patients. Although there was no difference between good and poor responders in pulmonary capillary wedge pressure at the end point of the exercise test after long-term beta-blcckade (good responders, 28. Relation between myoeardial fibrosis and left ventiular functinn. Although there was a considerable difference in the extent and type of myocarchal fibrosis between good and poor responders in this study, there aa$ nn difference in the degree of left ventricular functional lmpalrment before the initiation of beta-blocker therapy. The finding that the1.e WBY no signiRcnnt correlation between the extent of fibrosis and left ventricular dysfunction in patients with dilated car& myopathy was similar to that in wports in previous enda. myacardial biopsy studies (20,21). However, this was no1 the case in other reports (Z&23). Thus, the relation between myocardial fibrosis and l&t ventrcular dysfunction remains controversial.
Catecholamine hypothesis: @ophpialagic consideratton of the typesolfibrosis. Plasma cstecholaminc lcvcl is known as a major predictive factor ot death in patients with heart failure (24). It has been reported (25) that a compensatory increase in sympathetic nerve actirity for the failing hean will lead to worsening of the failing status by means of beta-receptor down regulation and catecholamine-induced cardiac toxicity. In the present study, the plasma concemration ofnorepinephrine before beta-blocker therapy tended to be higher in good than in poor responders Limit&ions ol this study. Because myocardial fibrosis was auantilied with the point-counting melhod in biopsy samples, there were some inherent limitations in the biopsy study. In terms of the reproducibility of mcasuremcnts by the point-counting method, the interobserver variability for percent fibrosis was small in this study (4.5 r 2%, n = 6). In addition, the determination of the dominant fibrosis type did not depend on observers. Another inherent iimitation was representativeness of the whole myoxardium in endomyocardiat biopsy samples. The morphologic changes in the myocardium were more or less uniformly distributed over the enlire myocardium in patients with dilated cardiomyop athy (23,261, although there might be some focal processes that could affect our quantitative analysis. However, it is evident that the effectiveness of long-term beta.blocler therapy could be related lo the myoeardial fibrosis content in palienls with dilated cardiomyopathy despite these Ii&a-dons. In addition, this is a retrospective study. Accordingly, another prospective trial using an external sample will be needed to verify our results.
Con+lusioas. This study showed that the tiectiveners of long-term hem-blocker therapy in patients whh dilated cardiomyopathy can be predicted from the histologic findings such as the severity and the dominant type of fibrosis in endomyoczrdial biopsy specimens.
